98 related articles for article (PubMed ID: 2867485)
1. (-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis.
Hjorth S; Carlsson A
Neuropharmacology; 1985 Nov; 24(11):1143-6. PubMed ID: 2867485
[TBL] [Abstract][Full Text] [Related]
2. Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?
Hjorth S; Carlsson A
Eur J Pharmacol; 1986 Sep; 129(1-2):131-8. PubMed ID: 2429847
[TBL] [Abstract][Full Text] [Related]
3. Both acute and subchronic treatments with pindolol, a 5-HT(1A) and β₁ and β₂ adrenoceptor antagonist, elevate regional serotonin synthesis in the rat brain: an autoradiographic study.
Skelin I; Fikre-Merid M; Diksic M
Neurochem Int; 2012 Dec; 61(8):1417-23. PubMed ID: 23084984
[TBL] [Abstract][Full Text] [Related]
4. Displacement of the binding of 5-HT(1A) receptor ligands to pre- and postsynaptic receptors by (-)pindolol. A comparative study in rodent, primate and human brain.
Raurich A; Mengod G; Artigas F; Cortés R
Synapse; 1999 Oct; 34(1):68-76. PubMed ID: 10459173
[TBL] [Abstract][Full Text] [Related]
5. Effects of milnacipran and pindolol on extracellular noradrenaline and serotonin levels in guinea pig hypothalamus.
Moret C; Briley M
J Neurochem; 1997 Aug; 69(2):815-22. PubMed ID: 9231743
[TBL] [Abstract][Full Text] [Related]
6. (-)-Pindolol increases dialysate concentrations of dopamine and noradrenaline, but not serotonin, in the frontal cortex of freely-moving rats.
Millan MJ; Gobert A
Neuropharmacology; 1999 Jun; 38(6):909-12. PubMed ID: 10465694
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.
Yamada K; Matsumoto S; Nagashima M; Shirakawa K; Furukawa T
J Neural Transm Gen Sect; 1990; 79(1-2):19-24. PubMed ID: 1967531
[TBL] [Abstract][Full Text] [Related]
8. (-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.
Assie MB; Koek W
Neuropharmacology; 1996 Feb; 35(2):213-22. PubMed ID: 8734491
[TBL] [Abstract][Full Text] [Related]
9. beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy.
Rabiner EA; Gunn RN; Castro ME; Sargent PA; Cowen PJ; Koepp MJ; Meyer JH; Bench CJ; Harrison PJ; Pazos A; Sharp T; Grasby PM
Neuropsychopharmacology; 2000 Sep; 23(3):285-93. PubMed ID: 10942852
[TBL] [Abstract][Full Text] [Related]
10. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
Ahlenius S; Hillegaart V; Wijkström A
Naunyn Schmiedebergs Arch Pharmacol; 1989 May; 339(5):551-6. PubMed ID: 2570361
[TBL] [Abstract][Full Text] [Related]
11. cis-(+)-8-OH-1-CH3-DPAT, (+)ALK-3, a novel stereoselective pharmacological probe for characterizing 5-HT release-controlling 5-HT1A autoreceptors. An in vivo brain microdialysis study.
Hjorth S; Sharp T; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 1990 Mar; 341(3):149-57. PubMed ID: 1692973
[TBL] [Abstract][Full Text] [Related]
12. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
Sharp T; McQuade R; Bramwell S; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
[TBL] [Abstract][Full Text] [Related]
13. Non-serotonergic potentiation by (-)-pindolol of DOI-induced forward locomotion in rats: possible involvement of beta-adrenoceptors?
Kaur P; Ahlenius S
J Neural Transm (Vienna); 2000; 107(8-9):903-17. PubMed ID: 11041271
[TBL] [Abstract][Full Text] [Related]
14. Effects of sustained (+/-)pindolol administration on serotonin neurotransmission in rats.
Haddjeri N; Blier P
J Psychiatry Neurosci; 2000 Sep; 25(4):378-88. PubMed ID: 11022403
[TBL] [Abstract][Full Text] [Related]
15. (-)-Propranolol and (+/-)-cyanopindolol are mixed agonists-antagonists at serotonin autoreceptors in the hippocampus of the rat brain.
Maura G; Ulivi M; Raiteri M
Neuropharmacology; 1987 Jul; 26(7A):713-7. PubMed ID: 3627379
[TBL] [Abstract][Full Text] [Related]
16. Chronic reserpine administration selectively up-regulates beta 1- and alpha 1b-adrenergic receptors in rat brain: an autoradiographic study.
Grimm LJ; Blendy JA; Kellar KJ; Perry DC
Neuroscience; 1992; 47(1):77-86. PubMed ID: 1315939
[TBL] [Abstract][Full Text] [Related]
17. An autoradiographic study of the influence of pindolol upon [35S]GTPgammaS binding in rat, guinea pig and human brain.
Serrats J; Artigas F; Mengod G; Cortés R
Int J Neuropsychopharmacol; 2004 Mar; 7(1):27-34. PubMed ID: 14720318
[TBL] [Abstract][Full Text] [Related]
18. Blockade of the central 5-HT autoreceptor by beta-adrenoceptor antagonists.
Middlemiss DN
Eur J Pharmacol; 1986 Jan; 120(1):51-6. PubMed ID: 2868904
[TBL] [Abstract][Full Text] [Related]
19. Effects of beta-adrenoceptor blocker pindolol, calcium antagonist verapamil and their combination on retention in step-down- and shuttle-box-trained rats and on brain biogenic monoamines.
Lazarova-Bakarova MB; Stancheva S; Petkova B; Genkova-Papasova M; Alova L; Boyanova E; Staneva-Stoytcheva D
J Physiol Paris; 1997 Dec; 91(6):301-5. PubMed ID: 9457662
[TBL] [Abstract][Full Text] [Related]
20. Pindolol suppresses serotonergic neuronal activity and does not block the inhibition of serotonergic neurons produced by 8-hydroxy-2-(di-n-propylamino)tetralin in awake cats.
Fornal CA; Martin FJ; Metzler CW; Jacobs BL
J Pharmacol Exp Ther; 1999 Oct; 291(1):229-38. PubMed ID: 10490909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
